Delta Asset Management’s Moderna MRNA Stock Holding History

Delta Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Hold	100	–	–	﹤0.01%	470
2026 Q1	$5.08K	Hold	100	–	–	﹤0.01%	486
2025 Q4	$2.95K	Hold	100	–	–	﹤0.01%	526
2025 Q3	$2.58K	Hold	100	–	–	﹤0.01%	533
2025 Q2	$2.76K	Hold	100	–	–	﹤0.01%	527
2025 Q1	$2.83K	Hold	100	–	–	﹤0.01%	525
2024 Q4	$4.16K	Hold	100	–	–	﹤0.01%	513
2024 Q3	$6.68K	Hold	100	–	–	﹤0.01%	477
2024 Q2	$11.9K	Hold	100	–	–	﹤0.01%	419
2024 Q1	$10.7K	Hold	100	–	–	﹤0.01%	446
2023 Q4	$9.95K	Hold	100	–	–	﹤0.01%	451
2023 Q3	$10.3K	Hold	100	–	–	﹤0.01%	438
2023 Q2	$12.2K	Hold	100	–	–	﹤0.01%	429
2023 Q1	$15.4K	Hold	100	–	–	﹤0.01%	375
2022 Q4	$18K	Buy	+100	New	+$16.4K	﹤0.01%	353
2022 Q1	–	Sell	-100	Closed	-$25K	–	404
2021 Q4	$25K	Hold	100	–	–	﹤0.01%	324
2021 Q3	$38K	Hold	100	–	–	﹤0.01%	264
2021 Q2	$23K	Hold	100	–	–	﹤0.01%	336
2021 Q1	$13K	Hold	100	–	–	﹤0.01%	403
2020 Q4	$10K	Hold	100	–	–	﹤0.01%	434
2020 Q3	$7K	Buy	+100	New	+$6.97K	﹤0.01%	448

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Delta Asset Management's MRNA Position: Q2 2026 in Review

Delta Asset Management held its Moderna (MRNA) position steady in Q2 2026 at 100 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

Delta Asset Management first reported a position in MRNA in Q3 2020 and has held it in 21 quarters since. The position peaked at $38K in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Delta Asset Management held 100 shares of Moderna worth $7K as of Q2 2026.
Delta Asset Management left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of Delta Asset Management's portfolio in Q2 2026, its #470 holding.
Delta Asset Management first reported a position in Moderna in Q3 2020 and has held it in 21 quarters since.
Delta Asset Management's Moderna position peaked at $38K in Q3 2021.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Delta Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.